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Introduction and Aims: Since the population in the developed world is aging, the
burden of fragility fractures is a constantly increasing problem. Despite the fact that
potent bone-specific pharmaceutical agents have become available, the problem of how
to identify patients with high fracture risk yet remains an enigma. Some studies
mention the role of a normal mineral metabolism is critical for skeletal development
and preservation of bone integrity. The aim of this study is to investigate the
association of mineral metabolism with hip fractures in type 2 diabetic with chronic
kidney disease (CKD).
Methods: In a observational study we included 107 type 2 diabetic patients with
chronic kidney disease (CKD) stages 2- 3, followed in our outpatient Diabetic Kidney
Clinic. We used descriptive statistics, the Student´s t and the chi-square tests. We also
divided our population according to the hip fractures, G I = without fractures (n=95)
and G2 = with fractures (n=12), and we compared these groups regarding the several
biological and laboratorial parameters analyzed. We employed a multivariate logistic
regressions model to identify risk factors of hip fractures.
Results: The mean age of these patients was 59.6 years, the mean eGFR (MDRD) was
43.5ml/min, and 37.4% (40) were female. We found that G2 patients showed higher age
(p=0.050), phosphorus (p=0.028), iPTH (p=0.021), FGF-23 (p=0.0001) and
osteocalcin (p=0.001) and lower levels of eGFR (p=0.0001), Klotho (p=0.0001) and 25
(OH)2D3 (p=0.002). In a multivariate logistic regression model adjusted to years,
gender, eGFR, calcium, phosphorus, iPTH, 25 (OH)2D3, osteocalcin, FGF-23, Klotho,
body and mass index, we found that 25 (OH)2D3 (OR= 0.772, p=0.037), Klotho (OR=
0.956, p=0.037) and FGF-23 (OR=1.008, p=0.0001) were independent risk factors of
hip fractures.
Conclusions: In your study the circulating 25 (OH)2D3, Klotho and FGF-23 are the
novel independent predictor of fracture risk in type 2 diabetic patients with chronic
kidney disease (CKD) stages 2- 3 Further clinical studies, with more patients are
required to study more precisely the role of bone metabolism and evaluate if the
therapeutic intervention can reduce the risk of the fractures.
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